Stay updated on Faricimab in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Faricimab in Diabetic Macular Edema Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No observable changes to trial details, eligibility criteria, endpoints, or results.SummaryDifference0.0%

- Check24 days agoChange DetectedPublications section wording updated to indicate voluntary submissions and PubMed auto-fill; revision tag changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check31 days agoChange DetectedThe top government funding/operating status notice was removed from the page.SummaryDifference0.1%

- Check46 days agoChange DetectedNo additions or deletions were detected on the page. The content remains focused on the study details, including design, outcomes, and locations.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a new publication reference under Publications: 'IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA' (Retina, 2025).SummaryDifference0.0%

- Check74 days agoChange DetectedCore content updated with a funding/operating status notice and a version upgrade from v3.0.2 to v3.2.0; no other substantive content changes detected.SummaryDifference0.6%

Stay in the know with updates to Faricimab in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.